These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35443950)

  • 1. Plasma-glycated CD59 as an early biomarker for gestational diabetes mellitus: prospective cohort study protocol.
    Andrews C; Toth-Castillo M; Aktas H; Fernandez ML; Wong SK; Sen S; Halperin J
    BMJ Open; 2022 Apr; 12(4):e054773. PubMed ID: 35443950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age Newborns.
    Ma D; Luque-Fernandez MA; Bogdanet D; Desoye G; Dunne F; Halperin JA;
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1033-40. PubMed ID: 32069353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of plasma glycated CD59 in predicting postpartum glucose intolerance: A prospective study of women diagnosed with GDM during a period of universal GDM screening.
    Bogdanet D; Castillo MT; Doheny H; Dervan L; Luque-Fernandez MA; Halperin J; O'Shea PM; Dunne FP
    Diabet Med; 2023 Sep; 40(9):e15121. PubMed ID: 37078256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in Ireland.
    Bogdanet D; Toth Castillo M; Doheny H; Dervan L; Angel Luque-Fernandez M; Halperin J; O'Shea PM; Dunne FP
    Diabetes Res Clin Pract; 2022 Aug; 190():110023. PubMed ID: 35907507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma glycated CD59 predicts postpartum glucose intolerance after gestational diabetes.
    Benhalima K; Ma DD; Laenen A; Mathieu C; Halperin JA
    Eur J Endocrinol; 2021 Oct; 185(5):755-763. PubMed ID: 34524975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma glycated CD59 (gCD59), a novel biomarker for the diagnosis, management and follow up of women with Gestational Diabetes (GDM) - protocol for prospective cohort study.
    Bogdanet D; O'Shea PM; Halperin J; Dunne F
    BMC Pregnancy Childbirth; 2020 Jul; 20(1):412. PubMed ID: 32682411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Glycated CD59, a Novel Biomarker for Detection of Pregnancy-Induced Glucose Intolerance.
    Ghosh P; Luque-Fernandez MA; Vaidya A; Ma D; Sahoo R; Chorev M; Zera C; McElrath TF; Williams MA; Seely EW; Halperin JA
    Diabetes Care; 2017 Jul; 40(7):981-984. PubMed ID: 28450368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland.
    Bogdanet D; Toth Castillo M; Doheny H; Dervan L; Luque-Fernandez MA; Halperin JA; O'Shea PM; Dunne FP
    J Clin Med; 2022 Jul; 11(13):. PubMed ID: 35807179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in Ireland.
    Bogdanet D; Castillo MT; Doheny H; Dervan L; Luque-Fernandez MA; Halperin JA; O'Shea PM; Dunne FP
    Acta Diabetol; 2023 Feb; 60(2):211-223. PubMed ID: 36309618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Early Pregnancy Maternal pGCD59 Levels in Predicting Neonatal Hypoglycemia-Subanalysis of the DALI Study.
    Bogdanet D; Luque-Fernandez MA; Toth-Castillo M; Desoye G; O'Shea PM; Dunne FP; Halperin JA
    J Clin Endocrinol Metab; 2022 Nov; 107(11):e4311-e4319. PubMed ID: 36054347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and diagnosing gestational diabetes mellitus.
    Hartling L; Dryden DM; Guthrie A; Muise M; Vandermeer B; Aktary WM; Pasichnyk D; Seida JC; Donovan L
    Evid Rep Technol Assess (Full Rep); 2012 Oct; (210):1-327. PubMed ID: 24423035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Diagnosed Gestational Diabetes Mellitus Is Associated With Adverse Pregnancy Outcomes: A Prospective Cohort Study.
    Liu B; Cai J; Xu Y; Long Y; Deng L; Lin S; Zhang J; Yang J; Zhong L; Luo Y; Zhou Y; Zhang Y; Li Z; Chen H; Wang Z
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32898218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinsulin in the identification and risk stratification of gestational diabetes mellitus: study protocol for a prospective, longitudinal cohort study.
    Peter R; Bright D; Cheung WY; Luzio SD; Dunseath GJ
    BMJ Open; 2018 Aug; 8(8):e022571. PubMed ID: 30158232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol on risk factors for the diagnosis of gestational diabetes mellitus in different trimesters and their relation to maternal and neonatal outcomes (GDM-RIDMAN).
    Yap PPH; Papachristou Nadal I; Rysinova V; Basri NI; Samsudin IN; Forbes A; Noor NM; Supian ZA; Hassan H; Paimin F; Zakaria R; Mohamed Alias SR; Ismail Bukhary NB; Benton M; Ismail K; Chew BH
    BMJ Open; 2022 Jul; 12(7):e052554. PubMed ID: 35882454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of gestational diabetes mellitus in early pregnancy by oral glucose tolerance test and glycosylated fibronectin: study protocol for an international, prospective, multicentre cohort trial.
    Huhn EA; Fischer T; Göbl CS; Todesco Bernasconi M; Kreft M; Kunze M; Schoetzau A; Dölzlmüller E; Eppel W; Husslein P; Ochsenbein-Koelble N; Zimmermann R; Bäz E; Prömpeler H; Bruder E; Hahn S; Hoesli I
    BMJ Open; 2016 Oct; 6(10):e012115. PubMed ID: 27733413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gestational diabetes mellitus (Update 2019)].
    Kautzky-Willer A; Harreiter J; Winhofer-Stöckl Y; Bancher-Todesca D; Berger A; Repa A; Lechleitner M; Weitgasser R
    Wien Klin Wochenschr; 2019 May; 131(Suppl 1):91-102. PubMed ID: 30980150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic of gestational diabetes mellitus and the prevalence of LGA (Large for Gestational Age)].
    Szymańska M; Bomba-Opoń DA; Celińska AM; Wielgoś M
    Ginekol Pol; 2008 Mar; 79(3):177-81. PubMed ID: 18592851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Quantose Insulin Resistance Test for Maternal Insulin Resistance: A Pilot Study.
    Eid J; Kechichian T; Benavides E; Thibodeaux L; Salazar AE; Saade GR; Saad AF
    Am J Perinatol; 2022 Apr; 39(5):513-518. PubMed ID: 32894869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feto-maternal outcomes in women with and without gestational diabetes mellitus according to the International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria.
    Nayak PK; Mitra S; Sahoo JP; Daniel M; Mathew A; Padma A
    Diabetes Metab Syndr; 2013; 7(4):206-9. PubMed ID: 24290085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of pregnancy outcomes and risk of LGA neonates in Caucasian females according to IADPSG criteria for gestational diabetes mellitus.
    Disse E; Graeppi-Dulac J; Joncour-Mills G; Dupuis O; Thivolet C
    Diabetes Metab; 2013 Apr; 39(2):132-8. PubMed ID: 23182459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.